According to a new report Global Antibiotics Market, published by KBV research, The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.
The Cell Wall Synthesis Inhibitors market dominated the Global Antibiotics Market by Action Mechanism in 2019, growing at a CAGR of 3.8 % during the forecast period. The Protein Synthesis Inhibitors market is expected to witness a CAGR of 4.3% during (2020 - 2026).
The Cephalosporin market dominated the Global Antibiotics Market by Drug Class in 2019. The Penicillin market is estimated to grow at a CAGR of 3.6% during (2020 - 2026). The Fluoroquinolone market would exhibit a CAGR of 6.4% during (2020 - 2026).
The Asia Pacific market dominated the Global Antibiotics Market by Region in 2019, due to the larger population, increasing cases of infectious disease, and lenient regulation on antibiotics drugs. It is also expected that it will continue to maintain its dominance during the forecast period. This is due to the increasing consumption of antibiotics, their easy availability, and the increasing sales of over-the-counter drugs. The Europe market is exhibiting a CAGR of 4.9% during (2020 - 2026). Additionally, The North America market would showcase a CAGR of 3.9% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/antibiotics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.
By Action Mechanism
By Drug Class
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
